Cost Effectiveness of Coronary Angiography and Calcium Scoring Using CT and Stress MRI for Diagnosis of Coronary Artery Disease
Overview
Authors
Affiliations
We compared the cost effectiveness of recent approaches [coronary angiography and calcium scoring using computed tomography (CT) and stress magnetic resonance imaging (MRI)] to the diagnosis of coronary artery disease (CAD) with those of the traditional diagnostic modalities [conventional angiography (CATH), exercise ECG, and stress echocardiography] using a decision tree model. For patients with a 10% to 50% pretest likelihood of coronary artery disease, non-invasive coronary angiography using CT was the most cost effective approach, with costs per correctly identified CAD patient of euro4,435 (10% likelihood) to euro1,469 (50% likelihood). Only for a pretest likelihood of 30% to 40% was calcium scoring using CT more cost effective than any of the traditional diagnostic modalities, while MRI was not cost effective for any pretest likelihood. At a pretest likelihood of 60%, CT coronary angiography and CATH were equally effective, while CATH was most cost effective for a pretest likelihood of at least 70%. In conclusion, up to a pretest likelihood for coronary artery disease of 50%, CT coronary angiography is the most cost-effective procedure, being superior to the other new modalities and the most commonly used traditional diagnostic modalities. With a very high likelihood for disease (above 60%), CATH is the most effective procedure from the perspective of society.
Vascular aging and cardiovascular disease: pathophysiology and measurement in the coronary arteries.
Cheng D, Climie R, Shu M, Grieve S, Kozor R, Figtree G Front Cardiovasc Med. 2023; 10:1206156.
PMID: 38089775 PMC: 10715672. DOI: 10.3389/fcvm.2023.1206156.
Burch R, Siddiqui T, Tou L, Turner K, Umair M J Cardiovasc Dev Dis. 2023; 10(1).
PMID: 36661920 PMC: 9863924. DOI: 10.3390/jcdd10010025.
Development of a Personalised Device for Systemic Magnetic Drug Targeting to Brain Tumours.
Patel P, Alghamdi A, Shaw G, Legge C, Glover M, Freeman D Nanotheranostics. 2023; 7(1):102-116.
PMID: 36593801 PMC: 9760367. DOI: 10.7150/ntno.76559.
Cost-effectiveness in diagnosis of stable angina patients: a decision-analytical modelling approach.
Nazir M, Rodriguez-Guadarrama Y, Rua T, Bui K, Buylova Gola A, Chiribiri A Open Heart. 2022; 9(1).
PMID: 35379740 PMC: 8981340. DOI: 10.1136/openhrt-2021-001700.
Gitto M, Gentile F, Nowbar A, Chieffo A, Al-Lamee R Int J Angiol. 2020; 29(4):250-255.
PMID: 33268976 PMC: 7690983. DOI: 10.1055/s-0040-1709500.